Remy Luthringer

Development of non-dopamine active drugs for negative symptoms

Most individuals affected by schizophrenia manifest negative symptoms. Because negative symptoms have a persistent deleterious effect on the social and vocational performance of the affected individuals, investigators in academia and pharmaceutical industry are making efforts to...